Evogene (EVGN) Set to Announce Earnings on Thursday

Evogene (NASDAQ:EVGN) is set to post its quarterly earnings results before the market opens on Thursday, November 21st. Investors that wish to register for the company’s conference call can do so using this link.

Evogene (NASDAQ:EVGN) last issued its quarterly earnings results on Thursday, August 22nd. The biotechnology company reported ($1.06) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.94). The business had revenue of $0.91 million during the quarter. Evogene had a negative return on equity of 72.33% and a negative net margin of 210.26%.

Evogene Price Performance

Shares of EVGN opened at $1.73 on Wednesday. Evogene has a 12-month low of $1.66 and a 12-month high of $10.40. The stock has a market capitalization of $9.26 million, a P/E ratio of -0.44 and a beta of 1.43. The firm’s 50 day moving average is $2.47 and its 200-day moving average is $4.56.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Lake Street Capital dropped their price target on Evogene from $30.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, August 23rd. StockNews.com started coverage on Evogene in a research report on Monday. They set a “sell” rating on the stock.

About Evogene

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications.